Medifast director Parsa Kiai buys over $1.13M in company stock
In a recent insider trading activity, Parsa Kiai, a director at Medifast Inc (NYSE:MED), acquired over $1.13 million worth of the company’s common stock in two separate transactions on November 18 and 19, 2026. The purchases, totaling 94,036 shares, were made at prices ranging from $11.855 to $12.20 per share. Despite the stock trading down over 9% in the past week, the insider buying comes as Medifast appears undervalued, with a Fair Value estimate of $16.58, positioning it among the most undervalued stocks.
The ownership of these shares is indirectly held by Steamboat Capital Partners Master Fund, LP, and Steamboat Capital Partners II, LP. This insider buying, following Medifast’s positive third-quarter 2026 financial results, suggests a potential confidence in the company’s turnaround efforts.
Brief written by urgent.news from Investing.com's own syndicated text. Machine-written; may contain errors — check the original.